Stockreport

Aptorum Group’s Subsidiary - Claves Life Sciences Limited Establishes Novel Therapeutic Platform for Treatment of Various Diseases via Modulation of the Chemical Signaling Relating to Gut ...

Aptorum Group Limited - Class A Ordinary Shares  (APM) 
PDF HONG KONG--(BUSINESS WIRE)-- Claves Life Sciences Limited, a wholly owned subsidiary of Aptorum Group Limited ("Aptorum") (Nasdaq: APM), is excited to anno [Read more]